Amrize Debuts as Independent, Publicly Traded Company
100% spin-off from Holcim complete Amrize begins trading on NYSE and SIX…
Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
 Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease…
